NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Mar 13, 2017
Insider Transaction Report
Form 4
Brown Robert S.
Sr. Vice President, CFO
Transactions
- Award
Stock Option (Right to Buy)
2017-03-09+39,884→ 39,884 totalExercise: $27.89From: 2017-04-09Exp: 2027-03-08→ Common Stock (39,884 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in 48 equal monthly installments beginning April 9, 2017.